| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.889 | 0.003 | 0.889 | Free radical scavenger | 0.542 0.012 CID_547 0.637 0.007 CID_68099 | ||
| 0.879 | 0.004 | 0.879 | Antioxidant | 0.528 0.017 CID_547 0.699 0.006 CID_68099 | ||
| 0.876 | 0.004 | 0.876 | Caspase 9 stimulant | 0.715 0.022 CID_547 0.787 0.013 CID_68099 | ||
| 0.845 | 0.004 | 0.916 | Aldehyde oxidase inhibitor | 0.761 0.005 CID_547 0.916 0.003 CID_68099 | CID_68099 | |
| 0.804 | 0.002 | 0.804 | Peroxidase inhibitor | 0.644 0.004 CID_547 0.561 0.005 CID_68099 | ||
| 0.797 | 0.004 | 0.797 | Amyloid beta aggregation inhibitor | 0.372 0.03 CID_547 0.342 0.036 CID_68099 | ||
| 0.798 | 0.006 | 0.798 | 15-Lipoxygenase inhibitor | 0.434 0.06 CID_547 0.444 0.056 CID_68099 | ||
| 0.789 | 0.002 | 0.789 | Cystathionine beta-synthase inhibitor | 0.524 0.003 CID_547 0.358 0.006 CID_68099 | ||
| 0.792 | 0.018 | 0.792 | Apoptosis agonist | 0.392 0.118 CID_547 0.748 0.023 CID_68099 | ||
| 0.749 | 0.005 | 0.749 | Caspase 3 stimulant | 0.303 0.077 CID_547 0.531 0.016 CID_68099 | ||
| 0.747 | 0.004 | 0.747 | Histamine release inhibitor | 0.627 0.008 CID_547 0.413 0.069 CID_68099 | ||
| 0.737 | 0.005 | 0.737 | 12-Lipoxygenase inhibitor | 0.387 0.043 CID_547 0.428 0.033 CID_68099 | ||
| 0.708 | 0.003 | 0.708 | GABA C receptor rho-3 antagonist | 0.461 0.038 CID_547 0.588 0.009 CID_68099 | ||
| 0.702 | 0.004 | 0.702 | Superoxide dismutase inhibitor | 0.634 0.005 CID_547 0.488 0.014 CID_68099 | ||
| 0.724 | 0.029 | 0.724 | Alpha-glucosidase inhibitor | 0.246 0.19 CID_547 0.572 0.06 CID_68099 | ||
| 0.67 | 0.001 | 0.67 | Creatine kinase inhibitor | 0.315 0.004 CID_547 0.28 0.004 CID_68099 | ||
| 0.664 | 0.004 | 0.664 | Monophenol monooxygenase inhibitor | 0.362 0.013 CID_547 0.456 0.009 CID_68099 | ||
| 0.661 | 0.003 | 0.661 | Xanthine oxidase inhibitor | 0.203 0.019 CID_547 0.314 0.007 CID_68099 | ||
| 0.665 | 0.006 | 0.665 | Lipoxygenase inhibitor | 0.465 0.024 CID_547 0.321 0.061 CID_68099 | ||
| 0.661 | 0.004 | 0.661 | MAO inhibitor | 0.228 0.033 CID_68099 | ||
| 0.659 | 0.004 | 0.659 | MAO A inhibitor | 0.162 0.038 CID_68099 | ||
| 0.663 | 0.025 | 0.663 | Transcription factor NF kappa B inhibitor | 0.547 0.038 CID_547 0.625 0.028 CID_68099 | ||
| 0.618 | 0.004 | 0.618 | Breast cancer-resistant protein inhibitor | 0.084 0.073 CID_547 | ||
| 0.611 | 0.004 | 0.611 | Melanin inhibitor | 0.343 0.017 CID_547 0.456 0.009 CID_68099 | ||
| 0.592 | 0.003 | 0.592 | Carbonic anhydrase III inhibitor | 0.28 0.006 CID_547 0.184 0.019 CID_68099 | ||
| 0.584 | 0.013 | 0.584 | 5 Hydroxytryptamine release inhibitor | 0.548 0.02 CID_547 0.427 0.062 CID_68099 | ||
| 0.571 | 0.004 | 0.571 | NOS3 expression enhancer | 0.232 0.031 CID_547 0.169 0.057 CID_68099 | ||
| 0.614 | 0.05 | 0.641 | Antiinflammatory | 0.641 0.043 CID_547 | CID_547 | |
| 0.568 | 0.004 | 0.568 | Interleukin 4 antagonist | 0.335 0.007 CID_547 0.179 0.03 CID_68099 | ||
| 0.565 | 0.013 | 0.637 | Apoptosis antagonist | 0.392 0.041 CID_547 0.637 0.006 CID_68099 | CID_68099 | |
| 0.56 | 0.01 | 0.56 | Hypoxia-inducible factor 1 alpha inhibitor | 0.328 0.053 CID_547 0.286 0.072 CID_68099 | ||
| 0.556 | 0.011 | 0.556 | Antiamyloidogenic | 0.303 0.051 CID_547 0.195 0.103 CID_68099 | ||
| 0.561 | 0.017 | 0.561 | Spasmolytic | 0.355 0.051 CID_547 0.252 0.09 CID_68099 | ||
| 0.56 | 0.018 | 0.56 | Aryl hydrocarbon receptor agonist | 0.155 0.132 CID_547 0.534 0.021 CID_68099 | ||
| 0.545 | 0.012 | 0.545 | Hypoglycemic | 0.523 0.013 CID_547 | ||
| 0.538 | 0.013 | 0.538 | Nitric oxide antagonist | 0.282 0.044 CID_547 0.384 0.027 CID_68099 | ||
| 0.511 | 0.005 | 0.511 | Lipid peroxidase inhibitor | 0.313 0.017 CID_547 0.356 0.012 CID_68099 | ||
| 0.511 | 0.005 | 0.511 | Amylase inhibitor | 0.432 0.008 CID_547 0.298 0.019 CID_68099 | ||
| 0.507 | 0.004 | 0.507 | NADPH oxidase inhibitor | 0.288 0.014 CID_547 0.136 0.065 CID_68099 | ||
| 0.499 | 0.004 | 0.549 | Estrogen receptor beta antagonist | 0.132 0.022 CID_547 0.549 0.003 CID_68099 | CID_68099 | |
| 0.491 | 0.003 | 0.491 | Carbonic anhydrase VI inhibitor | 0.266 0.008 CID_547 0.106 0.035 CID_68099 | ||
| 0.49 | 0.005 | 0.555 | 5 Hydroxytryptamine uptake stimulant | 0.555 0.003 CID_547 0.363 0.022 CID_68099 | CID_547 | |
| 0.481 | 0.004 | 0.498 | Estrogen antagonist | 0.153 0.022 CID_547 0.498 0.004 CID_68099 | CID_68099 | |
| 0.482 | 0.005 | 0.482 | MAO B inhibitor | 0.183 0.028 CID_68099 | ||
| 0.476 | 0.007 | 0.476 | Topoisomerase II inhibitor | 0.095 0.091 CID_547 0.223 0.029 CID_68099 | ||
| 0.473 | 0.005 | 0.473 | Acetylcholinesterase inhibitor | |||
| 0.47 | 0.01 | 0.47 | P-glycoprotein inhibitor | 0.204 0.061 CID_547 | ||
| 0.464 | 0.012 | 0.464 | Pyruvate kinase inhibitor | 0.281 0.053 CID_547 0.418 0.017 CID_68099 | ||
| 0.455 | 0.004 | 0.455 | Carbonic anhydrase XV inhibitor | 0.223 0.015 CID_547 0.185 0.021 CID_68099 | ||
| 0.467 | 0.017 | 0.467 | DNA damaging | 0.245 0.083 CID_547 0.277 0.067 CID_68099 | ||
| 0.449 | 0.004 | 0.449 | Carbonic anhydrase XIII inhibitor | 0.211 0.013 CID_547 0.24 0.009 CID_68099 | ||
| 0.448 | 0.01 | 0.448 | Hepatoprotectant | 0.273 0.037 CID_547 0.302 0.029 CID_68099 | ||
| 0.445 | 0.014 | 0.445 | RNA-directed DNA polymerase inhibitor | 0.269 0.04 CID_547 0.306 0.03 CID_68099 | ||
| 0.449 | 0.023 | 0.449 | Vasodilator, coronary | 0.368 0.047 CID_547 0.245 0.14 CID_68099 | ||
| 0.424 | 0.004 | 0.424 | Estrogen receptor alpha antagonist | 0.111 0.022 CID_547 0.257 0.006 CID_68099 | ||
| 0.436 | 0.018 | 0.436 | Vasodilator | 0.277 0.056 CID_547 | ||
| 0.425 | 0.006 | 0.425 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.35 0.013 CID_547 0.306 0.022 CID_68099 | ||
| 0.418 | 0.003 | 0.418 | Nitric-oxide synthase stimulant | 0.31 0.009 CID_547 0.277 0.018 CID_68099 | ||
| 0.417 | 0.004 | 0.417 | M18 aspartyl aminopeptidase inhibitor | 0.299 0.013 CID_547 0.205 0.032 CID_68099 | ||
| 0.417 | 0.005 | 0.417 | 5-Lipoxygenase inhibitor | 0.31 0.01 CID_547 0.154 0.036 CID_68099 | ||
| 0.414 | 0.011 | 0.414 | Tubulin antagonist | 0.161 0.053 CID_547 0.185 0.042 CID_68099 | ||
| 0.407 | 0.005 | 0.407 | Topoisomerase II alpha inhibitor | 0.075 0.057 CID_547 0.212 0.013 CID_68099 | ||
| 0.402 | 0.004 | 0.402 | Opioid kappa receptor antagonist | |||
| 0.401 | 0.004 | 0.401 | Macrophage migration inhibitory factor inhibitor | 0.213 0.007 CID_547 0.254 0.005 CID_68099 | ||
| 0.413 | 0.016 | 0.413 | Transcription factor STAT inhibitor | 0.219 0.113 CID_547 0.25 0.086 CID_68099 | ||
| 0.395 | 0.003 | 0.395 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.157 0.017 CID_547 0.308 0.004 CID_68099 | ||
| 0.448 | 0.057 | 0.482 | Antibacterial | 0.337 0.11 CID_547 0.482 0.046 CID_68099 | CID_68099 | |
| 0.39 | 0.003 | 0.39 | Xanthine dehydrogenase inhibitor | 0.087 0.02 CID_547 0.174 0.005 CID_68099 | ||
| 0.383 | 0.004 | 0.383 | GABA C receptor rho-2 antagonist | 0.188 0.036 CID_547 0.233 0.016 CID_68099 | ||
| 0.375 | 0.004 | 0.375 | Beta glucuronidase inhibitor | 0.12 0.046 CID_547 0.295 0.006 CID_68099 | ||
| 0.374 | 0.004 | 0.374 | Estrogen agonist | 0.077 0.024 CID_547 0.316 0.005 CID_68099 | ||
| 0.372 | 0.007 | 0.372 | Chelator | 0.282 0.013 CID_547 0.131 0.045 CID_68099 | ||
| 0.402 | 0.038 | 0.402 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.24 0.081 CID_547 0.185 0.109 CID_68099 | ||
| 0.374 | 0.011 | 0.374 | Cholinergic | |||
| 0.421 | 0.061 | 0.421 | Prostaglandin dehydrogenase inhibitor | 0.272 0.116 CID_68099 | ||
| 0.375 | 0.017 | 0.375 | Dual specificity phosphatase inhibitor | 0.324 0.025 CID_547 0.332 0.024 CID_68099 | ||
| 0.372 | 0.017 | 0.372 | Dual specificity phosphatase 3 inhibitor | 0.338 0.023 CID_547 0.331 0.024 CID_68099 | ||
| 0.358 | 0.004 | 0.478 | HIV-1 integrase (3'-Processing) inhibitor | 0.251 0.006 CID_547 0.478 0.004 CID_68099 | CID_68099 | |
| 0.352 | 0.004 | 0.352 | Uric acid excretion stimulant | 0.222 0.01 CID_547 0.148 0.024 CID_68099 | ||
| 0.353 | 0.012 | 0.462 | Protein-tyrosine phosphatase inhibitor | 0.302 0.019 CID_547 0.462 0.005 CID_68099 | CID_68099 | |
| 0.347 | 0.009 | 0.434 | Neurotrophic factor enhancer | 0.393 0.006 CID_547 0.434 0.005 CID_68099 | CID_68099 | |
| 0.382 | 0.049 | 0.494 | 5 Hydroxytryptamine release stimulant | 0.494 0.028 CID_547 0.342 0.058 CID_68099 | CID_547 | |
| 0.336 | 0.004 | 0.336 | Protein kinase C zeta inhibitor | 0.18 0.014 CID_68099 | ||
| 0.339 | 0.008 | 0.339 | Alkaline phosphatase inhibitor | 0.207 0.031 CID_547 0.208 0.03 CID_68099 | ||
| 0.334 | 0.004 | 0.334 | Aldose reductase inhibitor | 0.297 0.005 CID_547 0.188 0.008 CID_68099 | ||
| 0.339 | 0.013 | 0.339 | Protein kinase stimulant | 0.274 0.021 CID_547 0.303 0.016 CID_68099 | ||
| 0.323 | 0.005 | 0.323 | Opioid antagonist | 0.076 0.075 CID_547 | ||
| 0.322 | 0.009 | 0.322 | Butyrylcholinesterase inhibitor | |||
| 0.317 | 0.005 | 0.548 | Histidine decarboxylase inhibitor | 0.548 0.002 CID_547 0.528 0.003 CID_68099 | CID_547 | |
| 0.328 | 0.018 | 0.328 | DNA methyltransferase I inhibitor | 0.319 0.02 CID_547 0.249 0.047 CID_68099 | ||
| 0.312 | 0.004 | 0.312 | Estrogen receptor beta agonist | 0.04 0.021 CID_547 0.24 0.004 CID_68099 | ||
| 0.332 | 0.024 | 0.339 | Platelet adhesion inhibitor | 0.339 0.022 CID_547 | CID_547 | |
| 0.318 | 0.01 | 0.503 | Aldehyde dehydrogenase inhibitor | 0.229 0.022 CID_547 0.503 0.004 CID_68099 | CID_68099 | |
| 0.329 | 0.022 | 0.739 | Tyrosine 3 hydroxylase inhibitor | 0.739 0.002 CID_547 0.377 0.011 CID_68099 | CID_547 | |
| 0.344 | 0.039 | 0.344 | Tumour necrosis factor alpha release inhibitor | 0.202 0.108 CID_547 | ||
| 0.306 | 0.004 | 0.306 | Multidrug resistance-associated protein 1 inhibitor | 0.122 0.046 CID_547 | ||
| 0.306 | 0.01 | 0.416 | Protein-tyrosine phosphatase 1B inhibitor | 0.234 0.02 CID_547 0.416 0.005 CID_68099 | CID_68099 | |
| 0.3 | 0.005 | 0.424 | HIV-1 integrase (Strand Transfer) inhibitor | 0.234 0.007 CID_547 0.424 0.004 CID_68099 | CID_68099 | |
| 0.297 | 0.005 | 0.297 | Alcohol dehydrogenase inhibitor | 0.252 0.008 CID_547 0.248 0.008 CID_68099 | ||
| 0.329 | 0.039 | 0.329 | Angiogenesis stimulant | 0.32 0.042 CID_547 0.183 0.104 CID_68099 | ||
| 0.289 | 0.004 | 0.289 | Histone deacetylase SIRT1 stimulant | 0.107 0.024 CID_68099 | ||
| 0.289 | 0.004 | 0.289 | Histone deacetylase stimulant | 0.107 0.024 CID_68099 | ||
| 0.3 | 0.018 | 0.3 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.286 | 0.005 | 0.286 | Opioid delta receptor antagonist | 0.055 0.05 CID_547 | ||
| 0.323 | 0.043 | 0.323 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.267 0.06 CID_68099 | ||
| 0.319 | 0.044 | 0.319 | Transcription factor STAT3 inhibitor | 0.238 0.094 CID_547 0.184 0.158 CID_68099 | ||
| 0.302 | 0.028 | 0.458 | Non-steroidal antiinflammatory agent | 0.458 0.009 CID_547 | CID_547 | |
| 0.278 | 0.005 | 0.278 | Opioid mu receptor antagonist | |||
| 0.3 | 0.028 | 0.329 | DNA methylase inhibitor | 0.329 0.02 CID_547 0.226 0.063 CID_68099 | CID_547 | |
| 0.275 | 0.003 | 0.415 | DOPA decarboxylase inhibitor | 0.415 0.001 CID_547 0.252 0.004 CID_68099 | CID_547 | |
| 0.281 | 0.014 | 0.43 | Succinate dehydrogenase inhibitor | 0.43 0.004 CID_547 0.311 0.009 CID_68099 | CID_547 | |
| 0.281 | 0.013 | 0.281 | Heat shock protein 90 antagonist | 0.273 0.015 CID_68099 | ||
| 0.315 | 0.05 | 0.389 | Insulysin inhibitor | 0.389 0.024 CID_547 0.286 0.068 CID_68099 | CID_547 | |
| 0.264 | 0.003 | 0.264 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.134 0.009 CID_547 0.082 0.024 CID_68099 | ||
| 0.279 | 0.018 | 0.297 | Heat shock protein 90 alpha antagonist | 0.297 0.015 CID_68099 | CID_68099 | |
| 0.282 | 0.022 | 0.282 | Amyloid beta precursor protein antagonist | 0.177 0.074 CID_547 | ||
| 0.258 | 0.009 | 0.258 | Telomerase inhibitor | |||
| 0.252 | 0.004 | 0.252 | Estradiol 17 beta-dehydrogenase inhibitor | 0.058 0.02 CID_547 0.209 0.004 CID_68099 | ||
| 0.361 | 0.115 | 0.692 | Cyclophilin D inhibitor | 0.692 0.015 CID_547 0.248 0.216 CID_68099 | CID_547 | |
| 0.246 | 0.004 | 0.246 | Carbonic anhydrase VII inhibitor | 0.05 0.028 CID_547 0.051 0.027 CID_68099 | ||
| 0.248 | 0.007 | 0.248 | Analgesic, opioid | |||
| 0.243 | 0.003 | 0.243 | D-Ala-D-Ala ligase inhibitor | 0.13 0.01 CID_547 0.143 0.006 CID_68099 | ||
| 0.269 | 0.029 | 0.274 | Mcl-1 antagonist | 0.237 0.04 CID_547 0.274 0.028 CID_68099 | CID_68099 | |
| 0.244 | 0.005 | 0.244 | GABA C receptor rho-1 antagonist | 0.189 0.01 CID_547 0.167 0.015 CID_68099 | ||
| 0.289 | 0.056 | 0.289 | Dyrk kinase inhibitor | 0.233 0.08 CID_68099 | ||
| 0.261 | 0.029 | 0.409 | Insulin sensitizer | 0.409 0.006 CID_547 0.224 0.051 CID_68099 | CID_547 | |
| 0.237 | 0.005 | 0.283 | Alpha tubulin antagonist | 0.107 0.014 CID_547 0.283 0.004 CID_68099 | CID_68099 | |
| 0.238 | 0.007 | 0.238 | Photosensitizer | 0.216 0.01 CID_547 0.182 0.017 CID_68099 | ||
| 0.239 | 0.007 | 0.239 | GABA C receptor antagonist | 0.217 0.01 CID_547 0.189 0.015 CID_68099 | ||
| 0.238 | 0.007 | 0.238 | Aromatase inhibitor | 0.062 0.04 CID_547 0.153 0.013 CID_68099 | ||
| 0.235 | 0.004 | 0.235 | Heat shock protein 70 antagonist | 0.183 0.011 CID_547 0.161 0.027 CID_68099 | ||
| 0.311 | 0.081 | 0.541 | Antithrombotic | 0.541 0.024 CID_547 | CID_547 | |
| 0.241 | 0.017 | 0.241 | Protein kinase (CK2) alpha inhibitor | 0.117 0.064 CID_547 | ||
| 0.273 | 0.05 | 0.316 | Psychostimulant | 0.316 0.039 CID_547 0.179 0.093 CID_68099 | CID_547 | |
| 0.224 | 0.005 | 0.224 | Transcription factor STAT6 inhibitor | 0.118 0.064 CID_547 0.175 0.011 CID_68099 | ||
| 0.225 | 0.008 | 0.225 | Urease inhibitor | 0.129 0.037 CID_547 0.124 0.042 CID_68099 | ||
| 0.22 | 0.005 | 0.22 | Opioid agonist | |||
| 0.22 | 0.004 | 0.22 | Estrogen receptor alpha agonist | 0.045 0.019 CID_547 0.19 0.005 CID_68099 | ||
| 0.222 | 0.015 | 0.222 | Protein kinase (CK2) inhibitor | 0.085 0.078 CID_547 | ||
| 0.213 | 0.007 | 0.213 | Beta tubulin antagonist | 0.088 0.026 CID_547 0.183 0.009 CID_68099 | ||
| 0.218 | 0.012 | 0.218 | Mediator release inhibitor | 0.187 0.017 CID_547 | ||
| 0.208 | 0.005 | 0.208 | Myeloperoxidase inhibitor | 0.093 0.044 CID_547 0.095 0.042 CID_68099 | ||
| 0.223 | 0.021 | 0.259 | Topoisomerase I inhibitor | 0.259 0.015 CID_68099 | CID_68099 | |
| 0.256 | 0.055 | 0.256 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.21 | 0.01 | 0.21 | AMP-activated protein kinase stimulant | 0.2 0.011 CID_547 0.128 0.042 CID_68099 | ||
| 0.21 | 0.01 | 0.21 | Dopamine D1 antagonist | 0.081 0.032 CID_68099 | ||
| 0.208 | 0.009 | 0.208 | Papain-like protease (SARS coronavirus) inhibitor | 0.125 0.07 CID_547 0.174 0.018 CID_68099 | ||
| 0.258 | 0.059 | 0.4 | Interleukin antagonist | 0.4 0.031 CID_547 | CID_547 | |
| 0.227 | 0.029 | 0.229 | Bone formation stimulant | 0.229 0.029 CID_547 0.147 0.062 CID_68099 | CID_547 | |
| 0.222 | 0.027 | 0.343 | Cyclooxygenase 1 inhibitor | 0.343 0.01 CID_547 0.106 0.094 CID_68099 | CID_547 | |
| 0.202 | 0.007 | 0.202 | Carbonic anhydrase V inhibitor | 0.202 0.007 CID_547 0.065 0.048 CID_68099 | ||
| 0.211 | 0.015 | 0.361 | Cyclooxygenase 3 inhibitor | 0.361 0.004 CID_547 0.13 0.066 CID_68099 | CID_547 | |
| 0.199 | 0.005 | 0.199 | Opioid mu receptor agonist | |||
| 0.198 | 0.004 | 0.198 | Protease activated receptor antagonist | |||
| 0.199 | 0.006 | 0.199 | Toll-Like receptor 4 antagonist | 0.138 0.029 CID_547 | ||
| 0.196 | 0.004 | 0.196 | Fatty acid synthase inhibitor | 0.067 0.028 CID_68099 | ||
| 0.228 | 0.038 | 0.228 | Tumour necrosis factor antagonist | 0.13 0.128 CID_547 | ||
| 0.198 | 0.008 | 0.198 | Electron transport complex I inhibitor | 0.11 0.062 CID_547 | ||
| 0.221 | 0.034 | 0.331 | Interferon gamma antagonist | 0.326 0.016 CID_547 0.331 0.016 CID_68099 | CID_68099 | |
| 0.225 | 0.04 | 0.225 | Histone acetyltransferase inhibitor | 0.173 0.109 CID_547 0.185 0.092 CID_68099 | ||
| 0.191 | 0.007 | 0.191 | Cyclin B3 inhibitor | 0.081 0.038 CID_68099 | ||
| 0.186 | 0.002 | 0.186 | Dopamine D5 agonist | 0.149 0.003 CID_547 0.086 0.005 CID_68099 | ||
| 0.216 | 0.035 | 0.296 | Cyclooxygenase inhibitor | 0.296 0.018 CID_547 | CID_547 | |
| 0.19 | 0.011 | 0.19 | Dopamine agonist | |||
| 0.189 | 0.011 | 0.22 | Prolactin inhibitor | 0.22 0.006 CID_547 0.162 0.018 CID_68099 | CID_547 | |
| 0.245 | 0.066 | 0.375 | Cyclic AMP phosphodiesterase inhibitor | 0.375 0.02 CID_547 0.157 0.141 CID_68099 | CID_547 | |
| 0.204 | 0.025 | 0.204 | Alkylator | 0.149 0.047 CID_547 0.149 0.047 CID_68099 | ||
| 0.27 | 0.092 | 0.27 | Streptokinase A inhibitor | 0.211 0.126 CID_68099 | ||
| 0.179 | 0.006 | 0.179 | Carbonic anhydrase VA inhibitor | 0.179 0.006 CID_547 0.071 0.045 CID_68099 | ||
| 0.237 | 0.065 | 0.237 | Antimitotic | |||
| 0.203 | 0.033 | 0.203 | Death-associated protein kinase 2 inhibitor | |||
| 0.174 | 0.005 | 0.174 | Opioid kappa receptor agonist | |||
| 0.179 | 0.01 | 0.258 | Keratolytic | 0.258 0.005 CID_547 0.165 0.012 CID_68099 | CID_547 | |
| 0.174 | 0.007 | 0.174 | Carbonic anhydrase VB inhibitor | 0.138 0.01 CID_547 0.056 0.038 CID_68099 | ||
| 0.193 | 0.026 | 0.223 | CF transmembrane conductance regulator agonist | 0.167 0.05 CID_547 0.223 0.012 CID_68099 | CID_68099 | |
| 0.182 | 0.016 | 0.311 | HIV-1 integrase (Overall Integration) inhibitor | 0.311 0.003 CID_547 0.158 0.022 CID_68099 | CID_547 | |
| 0.19 | 0.025 | 0.228 | Farnesoid X receptor antagonist | 0.228 0.015 CID_547 0.187 0.026 CID_68099 | CID_547 | |
| 0.195 | 0.03 | 0.233 | DNA polymerase I inhibitor | 0.233 0.02 CID_547 0.103 0.082 CID_68099 | CID_547 | |
| 0.168 | 0.004 | 0.168 | Aryl hydrocarbon receptor antagonist | |||
| 0.19 | 0.029 | 0.258 | Toll-Like receptor 2 antagonist | 0.258 0.008 CID_547 0.257 0.008 CID_68099 | CID_547 | |
| 0.316 | 0.157 | 0.316 | DNA polymerase beta inhibitor | 0.217 0.212 CID_547 0.305 0.163 CID_68099 | ||
| 0.165 | 0.008 | 0.165 | Lipase inhibitor | 0.082 0.041 CID_547 0.075 0.048 CID_68099 | ||
| 0.173 | 0.017 | 0.173 | Androgen antagonist | 0.167 0.018 CID_68099 | ||
| 0.251 | 0.096 | 0.375 | Immunostimulant | 0.343 0.066 CID_547 0.375 0.057 CID_68099 | CID_68099 | |
| 0.191 | 0.036 | 0.196 | Hemostatic | 0.196 0.034 CID_547 | CID_547 | |
| 0.178 | 0.025 | 0.178 | Beta amyloid protein antagonist | 0.101 0.088 CID_547 | ||
| 0.192 | 0.041 | 0.264 | Arachidonic acid antagonist | 0.264 0.004 CID_547 0.206 0.027 CID_68099 | CID_547 | |
| 0.185 | 0.036 | 0.199 | Cyclooxygenase 2 inhibitor | 0.199 0.031 CID_547 | CID_547 | |
| 0.167 | 0.019 | 0.167 | DNA repair enzyme inhibitor | 0.122 0.069 CID_547 0.108 0.102 CID_68099 | ||
| 0.18 | 0.032 | 0.35 | Cholesterol synthesis inhibitor | 0.35 0.007 CID_547 0.151 0.044 CID_68099 | CID_547 | |
| 0.15 | 0.003 | 0.154 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.023 0.015 CID_547 0.154 0.003 CID_68099 | CID_68099 | |
| 0.192 | 0.049 | 0.427 | Phospholipase C inhibitor | 0.413 0.009 CID_547 0.427 0.009 CID_68099 | CID_68099 | |
| 0.148 | 0.009 | 0.173 | HIV-1 integrase inhibitor | 0.173 0.006 CID_547 0.164 0.007 CID_68099 | CID_547 | |
| 0.18 | 0.042 | 0.263 | Mannose-6-phosphate isomerase inhibitor | 0.232 0.017 CID_547 0.263 0.009 CID_68099 | CID_68099 | |
| 0.171 | 0.034 | 0.251 | Adenylate cyclase stimulant | 0.251 0.004 CID_547 0.181 0.025 CID_68099 | CID_547 | |
| 0.177 | 0.042 | 0.178 | Cell wall synthesis inhibitor | 0.178 0.041 CID_547 0.116 0.106 CID_68099 | CID_547 | |
| 0.14 | 0.005 | 0.14 | Opioid delta receptor agonist | |||
| 0.14 | 0.005 | 0.14 | Heat shock protein 90 beta antagonist | 0.085 0.018 CID_68099 | ||
| 0.286 | 0.152 | 0.286 | Analgesic | |||
| 0.159 | 0.025 | 0.276 | TRPA1 agonist | 0.219 0.008 CID_547 0.276 0.005 CID_68099 | CID_68099 | |
| 0.147 | 0.018 | 0.171 | Thioredoxin inhibitor | 0.102 0.046 CID_547 0.171 0.012 CID_68099 | CID_68099 | |
| 0.177 | 0.053 | 0.229 | Neurotensin receptor agonist | 0.229 0.025 CID_547 0.17 0.063 CID_68099 | CID_547 | |
| 0.13 | 0.007 | 0.171 | CD45 antagonist | 0.092 0.01 CID_547 0.171 0.005 CID_68099 | CID_68099 | |
| 0.288 | 0.168 | 0.295 | DNA directed DNA polymerase inhibitor | 0.226 0.208 CID_547 0.295 0.164 CID_68099 | CID_68099 | |
| 0.124 | 0.004 | 0.161 | Catechol O-methyltransferase inhibitor | 0.139 0.004 CID_547 0.161 0.004 CID_68099 | CID_68099 | |
| 0.125 | 0.006 | 0.125 | Carbonic anhydrase XIV inhibitor | 0.092 0.013 CID_547 0.047 0.036 CID_68099 | ||
| 0.134 | 0.015 | 0.181 | CDC25A inhibitor | 0.181 0.009 CID_547 0.071 0.055 CID_68099 | CID_547 | |
| 0.165 | 0.047 | 0.547 | Alpha-N-acetylglucosaminidase inhibitor | 0.547 0.004 CID_547 0.46 0.006 CID_68099 | CID_547 | |
| 0.127 | 0.01 | 0.171 | Neuraminidase (influenza) inhibitor | 0.065 0.044 CID_547 0.171 0.005 CID_68099 | CID_68099 | |
| 0.171 | 0.055 | 0.397 | Insulin secretagoues | 0.397 0.006 CID_547 | CID_547 | |
| 0.119 | 0.004 | 0.119 | GABA B receptor antagonist | 0.046 0.024 CID_547 0.063 0.011 CID_68099 | ||
| 0.117 | 0.004 | 0.117 | Transcription factor RelA inhibitor | 0.062 0.049 CID_547 0.072 0.027 CID_68099 | ||
| 0.245 | 0.131 | 0.479 | Vasodilator, peripheral | 0.479 0.032 CID_547 0.203 0.173 CID_68099 | CID_547 | |
| 0.117 | 0.005 | 0.162 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.035 0.024 CID_547 0.162 0.004 CID_68099 | CID_68099 | |
| 0.176 | 0.063 | 0.266 | ATPase inhibitor | 0.266 0.01 CID_547 0.153 0.096 CID_68099 | CID_547 | |
| 0.119 | 0.01 | 0.119 | Neuraminidase inhibitor | 0.054 0.052 CID_547 0.118 0.01 CID_68099 | ||
| 0.13 | 0.023 | 0.185 | CYP2A6 inhibitor | 0.185 0.009 CID_68099 | CID_68099 | |
| 0.188 | 0.081 | 0.537 | Anesthetic general | 0.537 0.006 CID_547 0.442 0.012 CID_68099 | CID_547 | |
| 0.126 | 0.021 | 0.146 | Ornithine decarboxylase inhibitor | 0.146 0.012 CID_547 0.14 0.014 CID_68099 | CID_547 | |
| 0.133 | 0.028 | 0.176 | Anabolic | 0.154 0.016 CID_547 0.176 0.008 CID_68099 | CID_68099 | |
| 0.117 | 0.013 | 0.119 | Protein kinase C eta inhibitor | 0.119 0.012 CID_68099 | CID_68099 | |
| 0.191 | 0.088 | 0.191 | MAP kinase kinase 2 inhibitor | |||
| 0.235 | 0.133 | 0.442 | Thyroid hormone antagonist | 0.442 0.045 CID_547 | CID_547 | |
| 0.126 | 0.025 | 0.126 | Phosphodiesterase 4D inhibitor | 0.101 0.036 CID_547 | ||
| 0.106 | 0.009 | 0.133 | Topoisomerase II beta inhibitor | 0.085 0.012 CID_547 0.133 0.006 CID_68099 | CID_68099 | |
| 0.17 | 0.073 | 0.17 | Antipruritic | 0.135 0.114 CID_547 | ||
| 0.147 | 0.051 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 CID_547 0.17 0.013 CID_68099 | CID_547 | |
| 0.114 | 0.019 | 0.141 | Leukotriene synthesis inhibitor | 0.141 0.011 CID_547 | CID_547 | |
| 0.117 | 0.022 | 0.796 | Glutamate decarboxylase inhibitor | 0.796 0.002 CID_547 0.218 0.005 CID_68099 | CID_547 | |
| 0.119 | 0.025 | 0.119 | Phosphodiesterase 6D inhibitor | 0.101 0.05 CID_547 | ||
| 0.102 | 0.009 | 0.106 | Glutamate (mGluR7) antagonist | 0.106 0.008 CID_547 0.084 0.023 CID_68099 | CID_547 | |
| 0.127 | 0.037 | 0.198 | Antineoplastic antibiotic | 0.198 0.021 CID_68099 | CID_68099 | |
| 0.111 | 0.021 | 0.111 | Thioredoxin reductase inhibitor | 0.076 0.075 CID_547 0.095 0.034 CID_68099 | ||
| 0.131 | 0.044 | 0.307 | Expectorant | 0.307 0.008 CID_547 0.244 0.013 CID_68099 | CID_547 | |
| 0.117 | 0.032 | 0.117 | Interleukin 12 antagonist | 0.11 0.039 CID_547 | ||
| 0.131 | 0.045 | 0.288 | Mucolytic | 0.288 0.005 CID_547 0.239 0.007 CID_68099 | CID_547 | |
| 0.104 | 0.019 | 0.104 | Carbonic anhydrase XII inhibitor | |||
| 0.112 | 0.028 | 0.214 | Bile acid receptor antagonist | 0.214 0.004 CID_547 0.105 0.039 CID_68099 | CID_547 | |
| 0.104 | 0.02 | 0.195 | Leukotriene antagonist | 0.195 0.006 CID_547 0.062 0.049 CID_68099 | CID_547 | |
| 0.123 | 0.039 | 0.24 | Potassium channel (Ca-activated) activator | 0.24 0.009 CID_547 0.086 0.068 CID_68099 | CID_547 | |
| 0.086 | 0.003 | 0.086 | Estrogen-related receptor beta antagonist | 0.052 0.005 CID_68099 | ||
| 0.175 | 0.094 | 0.175 | I kappa B kinase epsilon inhibitor | |||
| 0.218 | 0.14 | 0.389 | Thyroid hormone beta antagonist | 0.389 0.057 CID_547 | CID_547 | |
| 0.091 | 0.012 | 0.161 | Leukotriene B4 antagonist | 0.161 0.005 CID_547 0.056 0.033 CID_68099 | CID_547 | |
| 0.134 | 0.057 | 0.243 | Adenylate cyclase inhibitor | 0.243 0.02 CID_547 0.159 0.04 CID_68099 | CID_547 | |
| 0.105 | 0.029 | 0.179 | Granulocyte macrophage colony stimulating factor agonist | 0.139 0.008 CID_547 0.179 0.004 CID_68099 | CID_68099 | |
| 0.088 | 0.012 | 0.088 | Dopamine D2 agonist | |||
| 0.135 | 0.061 | 0.247 | Antibacterial (Helicobacter pylori) | 0.164 0.036 CID_547 0.247 0.012 CID_68099 | CID_68099 | |
| 0.199 | 0.125 | 0.345 | DNA synthesis inhibitor | 0.266 0.057 CID_547 0.345 0.031 CID_68099 | CID_68099 | |
| 0.083 | 0.009 | 0.084 | Squalene epoxidase inhibitor | 0.065 0.017 CID_547 0.084 0.008 CID_68099 | CID_68099 | |
| 0.103 | 0.029 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.097 0.034 CID_547 0.115 0.02 CID_68099 | CID_68099 | |
| 0.093 | 0.02 | 0.095 | MAP kinase kinase 7 inhibitor | 0.09 0.025 CID_547 0.095 0.018 CID_68099 | CID_68099 | |
| 0.227 | 0.154 | 0.447 | Sodium/bile acid cotransporter inhibitor | 0.447 0.008 CID_547 0.262 0.116 CID_68099 | CID_547 | |
| 0.13 | 0.058 | 0.15 | Proteasome inhibitor | 0.15 0.046 CID_547 0.114 0.071 CID_68099 | CID_547 | |
| 0.09 | 0.018 | 0.104 | Beta 3 adrenoreceptor antagonist | 0.104 0.013 CID_547 | CID_547 | |
| 0.098 | 0.026 | 0.579 | Phenylalanine 4-hydroxylase inhibitor | 0.579 0.002 CID_547 0.144 0.013 CID_68099 | CID_547 | |
| 0.098 | 0.027 | 0.164 | Estrogen-related receptor beta agonist | 0.164 0.004 CID_547 0.117 0.011 CID_68099 | CID_547 | |
| 0.091 | 0.02 | 0.121 | Maillard reaction inhibitor | 0.121 0.01 CID_547 0.062 0.033 CID_68099 | CID_547 | |
| 0.12 | 0.049 | 0.616 | GABA C receptor agonist | 0.616 0.003 CID_547 0.323 0.008 CID_68099 | CID_547 | |
| 0.14 | 0.069 | 0.14 | Toll-Like receptor 9 antagonist | |||
| 0.076 | 0.006 | 0.076 | Arginase inhibitor | 0.061 0.01 CID_547 | ||
| 0.232 | 0.164 | 0.345 | Immunosuppressant | 0.345 0.09 CID_547 | CID_547 | |
| 0.101 | 0.032 | 0.101 | mTOR complex 2 inhibitor | 0.079 0.07 CID_68099 | ||
| 0.114 | 0.046 | 0.116 | Sphingomyelinase inhibitor | 0.116 0.044 CID_547 | CID_547 | |
| 0.199 | 0.132 | 0.199 | 5 Hydroxytryptamine 1E antagonist | 0.198 0.133 CID_547 | ||
| 0.08 | 0.012 | 0.08 | Dopamine D5 antagonist | |||
| 0.115 | 0.047 | 0.335 | UDP-glucose 4-epimerase inhibitor | 0.244 0.014 CID_547 0.335 0.009 CID_68099 | CID_68099 | |
| 0.138 | 0.072 | 0.138 | Cytokine production inhibitor | |||
| 0.081 | 0.015 | 0.081 | Sphingosine kinase inhibitor | 0.078 0.017 CID_547 0.057 0.045 CID_68099 | ||
| 0.104 | 0.04 | 0.199 | NADH dehydrogenase inhibitor | 0.199 0.01 CID_547 0.156 0.016 CID_68099 | CID_547 | |
| 0.076 | 0.012 | 0.078 | Ryanodine receptor antagonist | 0.078 0.01 CID_547 0.064 0.029 CID_68099 | CID_547 | |
| 0.151 | 0.088 | 0.236 | Interleukin 6 antagonist | 0.236 0.026 CID_547 | CID_547 | |
| 0.142 | 0.08 | 0.142 | MAP kinase kinase 4 inhibitor | |||
| 0.066 | 0.005 | 0.066 | Protein kinase (CK2) beta inhibitor | 0.046 0.009 CID_68099 | ||
| 0.066 | 0.005 | 0.066 | Dopamine autoreceptor agonist | |||
| 0.083 | 0.023 | 0.52 | Alcohol oxidase inhibitor | 0.52 0.004 CID_547 0.467 0.004 CID_68099 | CID_547 | |
| 0.142 | 0.083 | 0.313 | Phospholipase A2 inhibitor | 0.313 0.012 CID_547 0.185 0.051 CID_68099 | CID_547 | |
| 0.069 | 0.011 | 0.069 | DNA-dependent protein kinase inhibitor | |||
| 0.072 | 0.015 | 0.14 | Glucose-6-phosphate translocase inhibitor | 0.075 0.013 CID_547 0.14 0.004 CID_68099 | CID_68099 | |
| 0.066 | 0.01 | 0.156 | Liver X receptor alpha agonist | 0.156 0.004 CID_547 | CID_547 | |
| 0.08 | 0.028 | 0.098 | CDC25B inhibitor | 0.098 0.017 CID_547 0.089 0.021 CID_68099 | CID_547 | |
| 0.057 | 0.005 | 0.11 | ATP citrate lysase inhibitor | 0.11 0.003 CID_547 0.035 0.017 CID_68099 | CID_547 | |
| 0.092 | 0.041 | 0.092 | Alpha 2a adrenoreceptor antagonist | |||
| 0.094 | 0.043 | 0.189 | Glutathione S-transferase inhibitor | 0.189 0.006 CID_547 0.074 0.072 CID_68099 | CID_547 | |
| 0.08 | 0.03 | 0.111 | Protein kinase C beta inhibitor | 0.111 0.009 CID_68099 | CID_68099 | |
| 0.072 | 0.023 | 0.072 | Sigma receptor antagonist | |||
| 0.054 | 0.004 | 0.054 | Dopamine D1 agonist | 0.026 0.012 CID_547 | ||
| 0.207 | 0.158 | 0.613 | Cholesterol antagonist | 0.613 0.017 CID_547 0.322 0.078 CID_68099 | CID_547 | |
| 0.173 | 0.125 | 0.195 | 5 Hydroxytryptamine 3E antagonist | 0.173 0.125 CID_547 0.195 0.072 CID_68099 | CID_68099 | |
| 0.07 | 0.022 | 0.243 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.083 0.015 CID_547 0.243 0.003 CID_68099 | CID_68099 | |
| 0.065 | 0.019 | 0.111 | Leukotriene C antagonist | 0.111 0.004 CID_547 0.054 0.047 CID_68099 | CID_547 | |
| 0.068 | 0.023 | 0.068 | Cyclin B2 inhibitor | |||
| 0.073 | 0.029 | 0.073 | Cyclin B1 inhibitor | |||
| 0.123 | 0.08 | 0.127 | Toll-Like receptor antagonist | 0.127 0.075 CID_68099 | CID_68099 | |
| 0.127 | 0.085 | 0.236 | Neurotrophic factor | 0.143 0.065 CID_547 0.236 0.015 CID_68099 | CID_68099 | |
| 0.074 | 0.033 | 0.112 | Beta adrenoreceptor antagonist | 0.112 0.012 CID_547 0.059 0.057 CID_68099 | CID_547 | |
| 0.112 | 0.074 | 0.28 | Interleukin 8 antagonist | 0.28 0.005 CID_547 0.177 0.02 CID_68099 | CID_547 | |
| 0.065 | 0.028 | 0.065 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.203 | 0.167 | 0.413 | Angiogenesis inhibitor | 0.413 0.049 CID_68099 | CID_68099 | |
| 0.12 | 0.087 | 0.29 | Vanilloid 1 agonist | 0.29 0.004 CID_547 0.133 0.061 CID_68099 | CID_547 | |
| 0.077 | 0.044 | 0.077 | MAP3K7 inhibitor | |||
| 0.084 | 0.052 | 0.085 | CC chemokine 5 receptor agonist | 0.083 0.055 CID_547 0.085 0.049 CID_68099 | CID_68099 | |
| 0.052 | 0.022 | 0.081 | Purinergic P2X4 antagonist | 0.081 0.006 CID_68099 | CID_68099 | |
| 0.077 | 0.047 | 0.077 | Phosphodiesterase VI inhibitor | |||
| 0.037 | 0.009 | 0.037 | Estrone sulfatase inhibitor | |||
| 0.087 | 0.059 | 0.087 | Alpha 2 adrenoreceptor antagonist | |||
| 0.125 | 0.099 | 0.215 | Diuretic | 0.215 0.039 CID_547 | CID_547 | |
| 0.033 | 0.007 | 0.05 | Leukotriene B4 receptor 2 antagonist | 0.05 0.004 CID_547 0.021 0.017 CID_68099 | CID_547 | |
| 0.055 | 0.03 | 0.086 | Beta 2 adrenoreceptor antagonist | 0.086 0.01 CID_547 0.053 0.033 CID_68099 | CID_547 | |
| 0.071 | 0.047 | 0.086 | Prostaglandin-E synthase inhibitor | 0.086 0.035 CID_547 | CID_547 | |
| 0.052 | 0.027 | 0.056 | Cholesterol esterase inhibitor | 0.056 0.022 CID_547 0.053 0.026 CID_68099 | CID_547 | |
| 0.075 | 0.051 | 0.72 | Porphobilinogen synthase inhibitor | 0.48 0.004 CID_547 0.72 0.002 CID_68099 | CID_68099 | |
| 0.046 | 0.023 | 0.046 | DNA gyrase subunit A inhibitor | 0.043 0.028 CID_68099 | ||
| 0.094 | 0.071 | 0.156 | Bronchodilator | 0.156 0.03 CID_547 | CID_547 | |
| 0.057 | 0.035 | 0.057 | Cyclin B inhibitor | |||
| 0.084 | 0.062 | 0.092 | Histamine N-methyltransferase inhibitor | 0.092 0.054 CID_547 0.078 0.069 CID_68099 | CID_547 | |
| 0.069 | 0.048 | 0.098 | Elastase 1 inhibitor | 0.098 0.021 CID_547 0.089 0.027 CID_68099 | CID_547 | |
| 0.061 | 0.04 | 0.075 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.075 0.023 CID_547 0.06 0.044 CID_68099 | CID_547 | |
| 0.089 | 0.068 | 0.246 | ABCA1 expression enhancer | 0.246 0.006 CID_547 | CID_547 | |
| 0.064 | 0.043 | 0.064 | Carbonic anhydrase inhibitor | |||
| 0.086 | 0.066 | 0.291 | Triose-phosphate isomerase inhibitor | 0.291 0.005 CID_547 0.194 0.012 CID_68099 | CID_547 | |
| 0.031 | 0.011 | 0.132 | Thyroid hormone agonist | 0.132 0.002 CID_547 0.028 0.014 CID_68099 | CID_547 | |
| 0.067 | 0.048 | 0.152 | Potassium channel large-conductance Ca-activated activator | 0.152 0.01 CID_547 0.061 0.058 CID_68099 | CID_547 | |
| 0.041 | 0.022 | 0.08 | Leukotriene C4 antagonist | 0.08 0.004 CID_547 | CID_547 | |
| 0.031 | 0.012 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 CID_547 0.028 0.016 CID_68099 | ||
| 0.034 | 0.016 | 0.066 | Leukotriene B4 receptor 1 antagonist | 0.066 0.005 CID_547 | CID_547 | |
| 0.074 | 0.056 | 0.257 | GABA B receptor agonist | 0.257 0.003 CID_547 0.098 0.018 CID_68099 | CID_547 | |
| 0.037 | 0.019 | 0.037 | Sirtuin 2 inhibitor | |||
| 0.035 | 0.018 | 0.035 | Protein kinase C beta I inhibitor | |||
| 0.036 | 0.018 | 0.078 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.034 0.02 CID_547 0.078 0.005 CID_68099 | CID_68099 | |
| 0.043 | 0.026 | 0.08 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.08 0.004 CID_547 0.074 0.004 CID_68099 | CID_547 | |
| 0.049 | 0.032 | 0.097 | Glucose-6-phosphate isomerase inhibitor | 0.097 0.005 CID_547 0.087 0.007 CID_68099 | CID_547 | |
| 0.029 | 0.013 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.025 0.019 CID_547 0.025 0.019 CID_68099 | ||
| 0.052 | 0.037 | 0.089 | Vanilloid 2 antagonist | 0.089 0.007 CID_547 | CID_547 | |
| 0.069 | 0.055 | 0.069 | Dopamine antagonist | |||
| 0.031 | 0.017 | 0.098 | Liver X receptor alpha antagonist | 0.098 0.004 CID_547 | CID_547 | |
| 0.09 | 0.076 | 0.09 | Alpha 2c adrenoreceptor antagonist | |||
| 0.054 | 0.041 | 0.085 | Dihydroorotate oxidase inhibitor | 0.082 0.009 CID_547 0.085 0.009 CID_68099 | CID_68099 | |
| 0.039 | 0.027 | 0.039 | Retinoic acid alpha receptor agonist | |||
| 0.067 | 0.055 | 0.067 | Secretase beta inhibitor | |||
| 0.05 | 0.038 | 0.064 | CXC chemokine 1 receptor antagonist | 0.064 0.017 CID_547 | CID_547 | |
| 0.044 | 0.033 | 0.076 | Neuraminidase (Influenza A) inhibitor | 0.076 0.005 CID_68099 | CID_68099 | |
| 0.071 | 0.06 | 0.219 | GABA aminotransferase inhibitor | 0.219 0.004 CID_547 0.211 0.004 CID_68099 | CID_547 | |
| 0.086 | 0.076 | 0.22 | Aminopeptidase B inhibitor | 0.22 0.017 CID_547 0.138 0.043 CID_68099 | CID_547 | |
| 0.041 | 0.032 | 0.041 | Carbonic anhydrase IV inhibitor | 0.039 0.034 CID_547 | ||
| 0.057 | 0.048 | 0.206 | Purinergic P2X1 antagonist | 0.151 0.007 CID_547 0.206 0.003 CID_68099 | CID_68099 | |
| 0.063 | 0.054 | 0.307 | Phosphofructokinase-1 inhibitor | 0.232 0.009 CID_547 0.307 0.005 CID_68099 | CID_68099 | |
| 0.058 | 0.051 | 0.058 | Dopamine D2 antagonist | |||
| 0.063 | 0.056 | 0.107 | Glutamate (mGluR6) antagonist | 0.107 0.008 CID_547 0.075 0.031 CID_68099 | CID_547 | |
| 0.044 | 0.037 | 0.065 | Adenosine deaminase inhibitor | 0.065 0.017 CID_547 | CID_547 | |
| 0.042 | 0.036 | 0.046 | Fructose-1,6-bisphosphatase inhibitor | 0.046 0.03 CID_547 | CID_547 | |
| 0.058 | 0.052 | 0.06 | Heme oxygenase stimulant | 0.06 0.046 CID_547 | CID_547 | |
| 0.028 | 0.025 | 0.098 | Liver X receptor antagonist | 0.098 0.005 CID_547 | CID_547 | |
| 0.03 | 0.026 | 0.03 | Estrogen-related receptor alpha antagonist | |||
| 0.117 | 0.114 | 0.256 | Thrombolytic | 0.256 0.032 CID_547 | CID_547 | |
| 0.047 | 0.045 | 0.047 | Carbonic anhydrase IX inhibitor | |||
| 0.06 | 0.058 | 0.06 | Sirtuin 1 inhibitor | |||
| 0.02 | 0.018 | 0.034 | Glutamate (mGluR1a) agonist | 0.034 0.007 CID_547 0.032 0.008 CID_68099 | CID_547 | |
| 0.041 | 0.04 | 0.064 | Adenylate cyclase 1 inhibitor | 0.064 0.015 CID_547 0.042 0.038 CID_68099 | CID_547 | |
| 0.035 | 0.034 | 0.086 | Glutamate (mGluR8) agonist | 0.086 0.004 CID_547 0.052 0.01 CID_68099 | CID_547 | |
| 0.071 | 0.071 | 0.074 | Phosphodiesterase IV inhibitor | 0.074 0.068 CID_547 | CID_547 | |
| 0.034 | 0.035 | 0.062 | Retinoid X receptor antagonist | 0.062 0.005 CID_547 | CID_547 | |
| 0.005 | 0.006 | 0.007 | Insulin like growth factor 3 antagonist | 0.007 0.004 CID_547 | CID_547 | |
| 0.089 | 0.09 | 0.305 | Adenylate kinase inhibitor | 0.305 0.007 CID_547 0.176 0.019 CID_68099 | CID_547 | |
| 0.04 | 0.042 | 0.048 | Potassium channel Kv1.3 blocker | 0.048 0.031 CID_68099 | CID_68099 | |
| 0.121 | 0.123 | 0.234 | Sphingosine 1-phosphate receptor 5 antagonist | 0.234 0.004 CID_547 0.132 0.095 CID_68099 | CID_547 | |
| 0.036 | 0.04 | 0.046 | Sphingosine kinase 1 inhibitor | 0.046 0.021 CID_547 | CID_547 | |
| 0.048 | 0.053 | 0.097 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.08 0.02 CID_547 0.097 0.015 CID_68099 | CID_68099 | |
| 0.025 | 0.031 | 0.037 | Estrogen-related receptor gamma antagonist | 0.035 0.009 CID_547 0.037 0.007 CID_68099 | CID_68099 | |
| 0.022 | 0.028 | 0.045 | Vanilloid 2 agonist | 0.045 0.003 CID_547 0.029 0.011 CID_68099 | CID_547 | |
| 0.016 | 0.023 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.005 CID_547 0.019 0.013 CID_68099 | CID_547 | |
| 0.05 | 0.057 | 0.066 | Androgen agonist | 0.066 0.034 CID_547 0.064 0.036 CID_68099 | CID_547 | |
| 0.116 | 0.124 | 0.186 | Hexokinase inhibitor | 0.186 0.044 CID_547 0.182 0.047 CID_68099 | CID_547 | |
| 0.044 | 0.052 | 0.158 | Aconitate hydratase inhibitor | 0.158 0.004 CID_547 0.085 0.012 CID_68099 | CID_547 | |
| 0.062 | 0.071 | 0.242 | Glutamate dehydrogenase inhibitor | 0.194 0.01 CID_547 0.242 0.007 CID_68099 | CID_68099 | |
| 0.002 | 0.013 | 0.006 | Transcortin receptor antagonist | 0.006 0.004 CID_68099 | CID_68099 | |
| 0.056 | 0.068 | 0.082 | Beta 2 adrenoreceptor agonist | 0.082 0.008 CID_547 0.065 0.031 CID_68099 | CID_547 | |
| 0.047 | 0.06 | 0.153 | Carbamoyl phosphate synthetase inhibitor | 0.153 0.011 CID_547 0.107 0.019 CID_68099 | CID_547 | |
| 0.005 | 0.018 | 0.087 | Thyroid hormone beta agonist | 0.087 0.002 CID_547 | CID_547 | |
| 0.017 | 0.03 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 CID_547 | CID_547 | |
| 0.02 | 0.034 | 0.088 | Liver X receptor beta antagonist | 0.088 0.004 CID_547 | CID_547 | |
| 0.11 | 0.125 | 0.21 | Sphingosine 1-phosphate receptor 2 antagonist | 0.21 0.006 CID_547 0.124 0.088 CID_68099 | CID_547 | |
| 0.012 | 0.028 | 0.018 | Antibiotic Tetracycline-like | 0.018 0.005 CID_68099 | CID_68099 | |
| 0.034 | 0.05 | 0.08 | Liver X receptor agonist | 0.08 0.01 CID_547 | CID_547 | |
| 0.05 | 0.067 | 0.057 | Transcription factor AP-1 inhibitor | 0.057 0.051 CID_547 | CID_547 | |
| 0.012 | 0.029 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_547 0.018 0.01 CID_68099 | CID_547 | |
| 0.011 | 0.029 | 0.018 | Purinergic P2Y1 agonist | 0.014 0.013 CID_547 0.018 0.008 CID_68099 | CID_68099 | |
| 0.01 | 0.028 | 0.253 | Thyroid hormone alpha antagonist | 0.253 0.003 CID_547 | CID_547 | |
| 0.016 | 0.036 | 0.057 | Prostaglandin F2 alpha agonist | 0.057 0.004 CID_547 0.026 0.011 CID_68099 | CID_547 | |
| 0.024 | 0.044 | 0.122 | Retinoid X alpha receptor agonist | 0.122 0.004 CID_547 | CID_547 | |
| 0.044 | 0.064 | 0.08 | Sphingosine kinase 2 inhibitor | 0.08 0.015 CID_547 0.053 0.042 CID_68099 | CID_547 | |
| 0.026 | 0.047 | 0.056 | Glutamate (mGluR3) agonist | 0.056 0.004 CID_547 0.053 0.004 CID_68099 | CID_547 | |
| 0.063 | 0.084 | 0.162 | Adrenaline agonist | 0.162 0.012 CID_547 0.077 0.062 CID_68099 | CID_547 | |
| 0.013 | 0.035 | 0.033 | Estrogen-related receptor gamma agonist | 0.033 0.004 CID_547 0.021 0.009 CID_68099 | CID_547 | |
| 0.06 | 0.081 | 0.13 | Glycine receptor agonist | 0.13 0.01 CID_547 0.109 0.017 CID_68099 | CID_547 | |
| 0.039 | 0.061 | 0.089 | Dopamine beta hydroxylase inhibitor | 0.089 0.004 CID_547 0.059 0.016 CID_68099 | CID_547 | |
| 0.036 | 0.059 | 0.135 | Plasminogen activator inhibitor antagonist | 0.135 0.005 CID_547 0.117 0.008 CID_68099 | CID_547 | |
| 0.037 | 0.061 | 0.048 | Heme oxygenase inhibitor | 0.048 0.016 CID_547 | CID_547 | |
| 0.04 | 0.063 | 0.065 | Beta adrenoreceptor agonist | 0.065 0.006 CID_547 | CID_547 | |
| 0.048 | 0.074 | 0.057 | Nitric oxide donor | 0.057 0.054 CID_547 | CID_547 | |
| 0.135 | 0.162 | 0.211 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.211 0.064 CID_68099 | CID_68099 | |
| 0.08 | 0.106 | 0.116 | 5 Hydroxytryptamine 3A agonist | 0.116 0.06 CID_68099 | CID_68099 | |
| 0.025 | 0.052 | 0.052 | Retinoid X alpha receptor antagonist | 0.052 0.005 CID_547 | CID_547 | |
| 0.01 | 0.038 | 0.026 | Nicotinic acid receptor 1 antagonist | 0.026 0.005 CID_547 0.018 0.011 CID_68099 | CID_547 | |
| 0.098 | 0.128 | 0.175 | Sphingosine 1-phosphate receptor 4 antagonist | 0.175 0.017 CID_547 0.167 0.021 CID_68099 | CID_547 | |
| 0.007 | 0.037 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 CID_547 0.013 0.009 CID_68099 | CID_547 | |
| 0.046 | 0.076 | 0.305 | Peroxisome proliferator-activated receptor gamma agonist | 0.305 0.005 CID_547 | CID_547 | |
| 0.014 | 0.044 | 0.055 | Leukotriene D4 antagonist | 0.055 0.009 CID_547 | CID_547 | |
| 0.065 | 0.095 | 0.089 | Inducible nitric-oxide synthase inhibitor | 0.089 0.049 CID_547 | CID_547 | |
| 0.042 | 0.072 | 0.084 | Heparanase inhibitor | 0.084 0.005 CID_547 | CID_547 | |
| 0.082 | 0.113 | 0.181 | Protein kinase C gamma inhibitor | 0.181 0.019 CID_68099 | CID_68099 | |
| 0.042 | 0.074 | 0.071 | TRPA1 antagonist | 0.071 0.031 CID_68099 | CID_68099 | |
| 0.029 | 0.061 | 0.171 | NMDA receptor subunit 3B antagonist | 0.171 0.005 CID_547 | CID_547 | |
| 0.019 | 0.051 | 0.033 | Progesterone antagonist | 0.033 0.026 CID_68099 | CID_68099 | |
| 0.07 | 0.103 | 0.311 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.311 0.005 CID_547 0.133 0.033 CID_68099 | CID_547 | |
| 0.03 | 0.063 | 0.042 | Vanilloid 3 antagonist | 0.042 0.018 CID_547 | CID_547 | |
| 0.005 | 0.038 | 0.032 | Glutamate (mGluR6) agonist | 0.032 0.003 CID_547 | CID_547 | |
| 0.025 | 0.059 | 0.048 | Oxytocin agonist | 0.044 0.028 CID_547 0.048 0.025 CID_68099 | CID_68099 | |
| 0.02 | 0.054 | 0.081 | Liver X receptor beta agonist | 0.081 0.006 CID_547 | CID_547 | |
| 0.035 | 0.069 | 0.099 | Lysophosphatidic acid 3 receptor antagonist | 0.099 0.005 CID_547 | CID_547 | |
| 0.02 | 0.056 | 0.049 | Phosphoglycerate kinase inhibitor | 0.049 0.014 CID_547 0.034 0.026 CID_68099 | CID_547 | |
| 0.068 | 0.107 | 0.11 | Interleukin 5 antagonist | 0.11 0.032 CID_547 | CID_547 | |
| 0.021 | 0.06 | 0.149 | NMDA receptor subunit 3A antagonist | 0.149 0.005 CID_547 | CID_547 | |
| 0.017 | 0.056 | 0.102 | Retinoid X receptor agonist | 0.102 0.004 CID_547 | CID_547 | |
| 0.048 | 0.087 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.07 0.037 CID_547 0.09 0.02 CID_68099 | CID_68099 | |
| 0.013 | 0.053 | 0.033 | Beta 1 adrenoreceptor agonist | 0.033 0.007 CID_547 | CID_547 | |
| 0.014 | 0.054 | 0.024 | Retinoid X beta receptor antagonist | 0.024 0.008 CID_547 | CID_547 | |
| 0.066 | 0.106 | 0.084 | Pim-1 kinase inhibitor | 0.084 0.075 CID_68099 | CID_68099 | |
| 0.017 | 0.057 | 0.037 | Glutamate (mGluR1) agonist | 0.037 0.006 CID_547 | CID_547 | |
| 0.019 | 0.059 | 0.099 | Fumarate hydratase inhibitor | 0.099 0.005 CID_547 0.045 0.016 CID_68099 | CID_547 | |
| 0.009 | 0.052 | 0.062 | Thyroid hormone alpha agonist | 0.062 0.003 CID_547 | CID_547 | |
| 0.05 | 0.093 | 0.166 | Aminopeptidase I inhibitor | 0.166 0.01 CID_547 0.097 0.03 CID_68099 | CID_547 | |
| 0.033 | 0.076 | 0.112 | Acyl-CoA dehydrogenase inhibitor | 0.112 0.014 CID_547 0.08 0.022 CID_68099 | CID_547 | |
| 0.035 | 0.079 | 0.058 | Prolyl endopeptidase inhibitor | 0.058 0.027 CID_547 0.057 0.028 CID_68099 | CID_547 | |
| 0.009 | 0.053 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.018 0.016 CID_68099 | CID_68099 | |
| 0.191 | 0.236 | 0.27 | Transcription factor inhibitor | 0.27 0.173 CID_68099 | CID_68099 | |
| 0.036 | 0.081 | 0.072 | Bombesin 2 receptor antagonist | 0.072 0.019 CID_547 | CID_547 | |
| 0.082 | 0.127 | 0.161 | Microtubule formation inhibitor | 0.161 0.032 CID_547 0.12 0.06 CID_68099 | CID_547 | |
| 0.032 | 0.078 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.027 CID_547 0.039 0.03 CID_68099 | CID_547 | |
| 0.022 | 0.069 | 0.044 | RNA-directed RNA polymerase inhibitor | 0.044 0.015 CID_547 | CID_547 | |
| 0.07 | 0.117 | 0.126 | Lanosterol 14 alpha demethylase inhibitor | 0.126 0.025 CID_547 | CID_547 | |
| 0.022 | 0.07 | 0.041 | Alpha 1d adrenoreceptor agonist | 0.041 0.024 CID_68099 | CID_68099 | |
| 0.036 | 0.085 | 0.182 | Biliverdin reductase inhibitor | 0.182 0.007 CID_547 0.102 0.018 CID_68099 | CID_547 | |
| 0.015 | 0.064 | 0.104 | Peroxisome proliferator-activated receptor delta agonist | 0.104 0.005 CID_547 | CID_547 | |
| 0.017 | 0.067 | 0.043 | Dopamine D3 agonist | 0.043 0.024 CID_68099 | CID_68099 | |
| 0.017 | 0.067 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 CID_547 | CID_547 | |
| 0.017 | 0.067 | 0.036 | Cholesterol ester transfer protein antagonist | 0.036 0.016 CID_547 | CID_547 | |
| 0.119 | 0.169 | 0.265 | 3C-like protease (Human coronavirus) inhibitor | 0.137 0.126 CID_547 0.265 0.022 CID_68099 | CID_68099 | |
| 0.068 | 0.119 | 0.267 | Vanilloid agonist | 0.267 0.005 CID_547 | CID_547 | |
| 0.015 | 0.065 | 0.039 | HCV NS5B polymerase inhibitor | 0.039 0.015 CID_547 | CID_547 | |
| 0.016 | 0.067 | 0.076 | 5-Alpha-reductase inhibitor | 0.076 0.013 CID_547 0.049 0.019 CID_68099 | CID_547 | |
| 0.005 | 0.057 | 0.036 | G-protein-coupled receptor 120 agonist | 0.036 0.004 CID_547 | CID_547 | |
| 0.023 | 0.076 | 0.144 | Peroxisome proliferator-activated receptor alpha agonist | 0.144 0.007 CID_547 | CID_547 | |
| 0.072 | 0.126 | 0.115 | Glutamate release inhibitor | 0.115 0.025 CID_547 0.1 0.042 CID_68099 | CID_547 | |
| 0.045 | 0.101 | 0.106 | Amidase inhibitor | 0.106 0.021 CID_547 | CID_547 | |
| 0.031 | 0.089 | 0.093 | Beta 1 adrenoreceptor antagonist | 0.093 0.012 CID_547 0.05 0.046 CID_68099 | CID_547 | |
| 0.021 | 0.079 | 0.063 | Macrophage elastase inhibitor | 0.063 0.017 CID_547 | CID_547 | |
| 0.025 | 0.084 | 0.046 | Leukocyte elastase inhibitor | 0.046 0.027 CID_547 | CID_547 | |
| 0.011 | 0.07 | 0.049 | Uridine phosphorylase inhibitor | 0.049 0.008 CID_547 | CID_547 | |
| 0.054 | 0.113 | 0.106 | Interferon agonist | 0.106 0.024 CID_547 | CID_547 | |
| 0.052 | 0.111 | 0.092 | Metalloproteinase-9 inhibitor | 0.092 0.037 CID_547 | CID_547 | |
| 0.183 | 0.242 | 0.409 | Calcium channel activator | 0.409 0.021 CID_547 0.318 0.075 CID_68099 | CID_547 | |
| 0.012 | 0.072 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 CID_547 0.017 0.015 CID_68099 | CID_547 | |
| 0.057 | 0.118 | 0.105 | Falcipain 2 inhibitor | 0.105 0.049 CID_68099 | CID_68099 | |
| 0.019 | 0.08 | 0.035 | Inosine monophosphate dehydrogenase inhibitor | 0.035 0.027 CID_68099 | CID_68099 | |
| 0.03 | 0.092 | 0.16 | Argininosuccinate synthase inhibitor | 0.16 0.01 CID_547 0.106 0.018 CID_68099 | CID_547 | |
| 0.029 | 0.092 | 0.089 | Kainate receptor agonist | 0.089 0.003 CID_547 0.045 0.021 CID_68099 | CID_547 | |
| 0.053 | 0.117 | 0.135 | Peroxisome proliferator-activated receptor gamma antagonist | 0.135 0.007 CID_547 0.076 0.04 CID_68099 | CID_547 | |
| 0.059 | 0.123 | 0.107 | Falcipain inhibitor | 0.107 0.05 CID_68099 | CID_68099 | |
| 0.044 | 0.109 | 0.192 | Cathepsin G inhibitor | 0.192 0.016 CID_547 | CID_547 | |
| 0.037 | 0.102 | 0.18 | Sphingosine 1-phosphate receptor 4 agonist | 0.18 0.005 CID_547 0.119 0.017 CID_68099 | CID_547 | |
| 0.005 | 0.071 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_547 | CID_547 | |
| 0.003 | 0.072 | 0.015 | Beta 3 adrenoreceptor agonist | 0.015 0.005 CID_547 | CID_547 | |
| 0.042 | 0.11 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 CID_547 | CID_547 | |
| 0.202 | 0.27 | 0.459 | Calcium channel L-type activator | 0.459 0.046 CID_547 0.358 0.111 CID_68099 | CID_547 | |
| 0.006 | 0.075 | 0.054 | Prostaglandin H2 antagonist | 0.054 0.003 CID_547 | CID_547 | |
| 0.043 | 0.113 | 0.057 | Immunoglobulin Fc receptor antagonist | 0.057 0.032 CID_547 | CID_547 | |
| 0.031 | 0.1 | 0.112 | NMDA receptor glycine site agonist | 0.112 0.011 CID_547 | CID_547 | |
| 0.011 | 0.081 | 0.077 | Prostacyclin antagonist | 0.077 0.006 CID_547 | CID_547 | |
| 0.016 | 0.086 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.023 CID_68099 | CID_68099 | |
| 0.037 | 0.107 | 0.048 | Factor III inhibitor | 0.048 0.039 CID_547 | CID_547 | |
| 0.021 | 0.093 | 0.057 | Guanylate cyclase inhibitor | 0.057 0.014 CID_547 0.044 0.027 CID_68099 | CID_547 | |
| 0.09 | 0.162 | 0.136 | Acetylcholine M1 receptor antagonist | 0.136 0.089 CID_547 | CID_547 | |
| 0.02 | 0.092 | 0.09 | Glutamate (mGluR3) antagonist | 0.09 0.005 CID_547 | CID_547 | |
| 0.03 | 0.103 | 0.064 | Glutamate (mGluR group III) antagonist | 0.064 0.011 CID_547 0.051 0.02 CID_68099 | CID_547 | |
| 0.048 | 0.121 | 0.109 | Metalloproteinase-2 inhibitor | 0.109 0.034 CID_547 | CID_547 | |
| 0.059 | 0.132 | 0.083 | Caspase 7 inhibitor | 0.083 0.054 CID_547 | CID_547 | |
| 0.006 | 0.08 | 0.023 | Alpha 2a adrenoreceptor agonist | 0.023 0.007 CID_68099 | CID_68099 | |
| 0.004 | 0.079 | 0.095 | Peroxisome proliferator-activated receptor alpha antagonist | 0.095 0.005 CID_547 | CID_547 | |
| 0.015 | 0.092 | 0.103 | Lysophosphatidic acid 2 receptor antagonist | 0.103 0.004 CID_547 | CID_547 | |
| 0.015 | 0.093 | 0.044 | Farnesoid X receptor agonist | 0.044 0.019 CID_547 | CID_547 | |
| 0.061 | 0.141 | 0.336 | Ferrochelatase inhibitor | 0.336 0.005 CID_547 0.192 0.024 CID_68099 | CID_547 | |
| 0.017 | 0.097 | 0.048 | Dihydropteroate synthase inhibitor | 0.048 0.018 CID_547 0.045 0.021 CID_68099 | CID_547 | |
| 0.024 | 0.104 | 0.127 | Thromboxane antagonist | 0.127 0.006 CID_547 | CID_547 | |
| 0.013 | 0.094 | 0.082 | Free fatty acid receptor 1 antagonist | 0.082 0.004 CID_547 | CID_547 | |
| 0.043 | 0.124 | 0.056 | Lipocortins synthesis agonist | 0.056 0.046 CID_547 | CID_547 | |
| 0.04 | 0.12 | 0.101 | Pregnane X receptor antagonist | 0.075 0.009 CID_547 0.101 0.004 CID_68099 | CID_68099 | |
| 0.064 | 0.145 | 0.153 | Interleukin 1 beta converting enzyme inhibitor | 0.153 0.016 CID_547 0.094 0.066 CID_68099 | CID_547 | |
| 0.02 | 0.101 | 0.041 | Oleamide hydrolase inhibitor | 0.041 0.036 CID_547 | CID_547 | |
| 0.011 | 0.093 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 CID_547 | CID_547 | |
| 0.005 | 0.088 | 0.025 | Aminopeptidase A inhibitor | 0.025 0.008 CID_547 | CID_547 | |
| 0.02 | 0.106 | 0.113 | Thromboxane A2 antagonist | 0.113 0.005 CID_547 0.044 0.041 CID_68099 | CID_547 | |
| 0.028 | 0.114 | 0.076 | Aminopeptidase microsomal inhibitor | 0.076 0.027 CID_547 | CID_547 | |
| 0.007 | 0.095 | 0.018 | Vitamin D receptor agonist | 0.018 0.008 CID_547 | CID_547 | |
| 0.076 | 0.164 | 0.109 | Acetylcholine release stimulant | 0.109 0.068 CID_547 | CID_547 | |
| 0.019 | 0.108 | 0.055 | GABA uptake inhibitor | 0.055 0.013 CID_547 0.041 0.025 CID_68099 | CID_547 | |
| 0.029 | 0.118 | 0.075 | Alpha-mannosidase inhibitor | 0.075 0.014 CID_547 0.066 0.02 CID_68099 | CID_547 | |
| 0.053 | 0.143 | 0.073 | Vanilloid 4 agonist | 0.073 0.056 CID_547 | CID_547 | |
| 0.018 | 0.108 | 0.027 | Hedgehog signaling activator | 0.027 0.02 CID_547 | CID_547 | |
| 0.033 | 0.124 | 0.092 | Thromboxane synthase inhibitor | 0.092 0.008 CID_547 | CID_547 | |
| 0.006 | 0.097 | 0.022 | Thromboxane A2 agonist | 0.022 0.005 CID_547 | CID_547 | |
| 0.048 | 0.139 | 0.091 | Glycine receptor antagonist | 0.091 0.042 CID_547 0.085 0.049 CID_68099 | CID_547 | |
| 0.005 | 0.096 | 0.015 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 CID_547 | CID_547 | |
| 0.005 | 0.096 | 0.015 | Carbonic anhydrase X inhibitor | 0.015 0.014 CID_547 | CID_547 | |
| 0.01 | 0.102 | 0.136 | Prostaglandin agonist | 0.136 0.004 CID_547 | CID_547 | |
| 0.011 | 0.104 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.034 0.008 CID_547 | CID_547 | |
| 0.01 | 0.102 | 0.036 | Lysine carboxypeptidase inhibitor | 0.036 0.012 CID_547 | CID_547 | |
| 0.016 | 0.11 | 0.03 | Complement factor 1s inhibitor | 0.03 0.008 CID_68099 | CID_68099 | |
| 0.014 | 0.109 | 0.099 | Urate transporter 1 inhibitor | 0.099 0.005 CID_547 | CID_547 | |
| 0.024 | 0.119 | 0.105 | NMDA 2C receptor antagonist | 0.105 0.014 CID_547 | CID_547 | |
| 0.041 | 0.137 | 0.085 | Interferon inducer | 0.085 0.02 CID_547 | CID_547 | |
| 0.123 | 0.219 | 0.237 | Calpain inhibitor | 0.225 0.09 CID_547 0.237 0.077 CID_68099 | CID_68099 | |
| 0.036 | 0.132 | 0.159 | NMDA receptor agonist | 0.159 0.007 CID_547 | CID_547 | |
| 0.017 | 0.113 | 0.079 | NMDA 2A receptor antagonist | 0.079 0.02 CID_547 | CID_547 | |
| 0.006 | 0.104 | 0.053 | Prostaglandin EP2 agonist | 0.053 0.005 CID_547 | CID_547 | |
| 0.004 | 0.102 | 0.011 | Egl nine homolog 3 inhibitor | 0.011 0.01 CID_547 | CID_547 | |
| 0.137 | 0.235 | 0.266 | Peptidyltransferase inhibitor | 0.266 0.04 CID_547 | CID_547 | |
| 0.008 | 0.107 | 0.026 | 5-Alpha-reductase 2 inhibitor | 0.026 0.01 CID_547 0.018 0.016 CID_68099 | CID_547 | |
| 0.018 | 0.118 | 0.082 | Ornithine carbamoyltransferase inhibitor | 0.082 0.021 CID_547 0.058 0.033 CID_68099 | CID_547 | |
| 0.022 | 0.124 | 0.049 | Glutamate (mGluR8) antagonist | 0.049 0.009 CID_547 | CID_547 | |
| 0.019 | 0.122 | 0.066 | Mannosidase inhibitor | 0.066 0.013 CID_547 0.053 0.023 CID_68099 | CID_547 | |
| 0.017 | 0.119 | 0.062 | Sphingosine 1-phosphate receptor 1 agonist | 0.062 0.012 CID_547 | CID_547 | |
| 0.045 | 0.151 | 0.075 | Exportin-1 inhibitor | 0.075 0.034 CID_547 | CID_547 | |
| 0.018 | 0.126 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 CID_547 | CID_547 | |
| 0.003 | 0.111 | 0.018 | Thromboxane agonist | 0.018 0.004 CID_547 | CID_547 | |
| 0.015 | 0.125 | 0.074 | Ribonucleoside-diphosphate reductase inhibitor | 0.074 0.027 CID_547 0.066 0.031 CID_68099 | CID_547 | |
| 0.017 | 0.127 | 0.054 | Aminopeptidase N inhibitor | 0.054 0.028 CID_547 | CID_547 | |
| 0.005 | 0.115 | 0.097 | Prostaglandin E2 agonist | 0.097 0.004 CID_547 | CID_547 | |
| 0.064 | 0.174 | 0.143 | Caspase 3 inhibitor | 0.143 0.034 CID_547 0.142 0.034 CID_68099 | CID_547 | |
| 0.014 | 0.125 | 0.075 | Ribonucleotide reductase inhibitor | 0.075 0.029 CID_547 0.067 0.032 CID_68099 | CID_547 | |
| 0.012 | 0.122 | 0.037 | Lysophosphatidic acid receptor 1 agonist | 0.037 0.007 CID_547 | CID_547 | |
| 0.076 | 0.187 | 0.15 | Interleukin 1 antagonist | 0.15 0.057 CID_547 | CID_547 | |
| 0.004 | 0.116 | 0.034 | Egl nine homolog 1 inhibitor | 0.034 0.004 CID_547 | CID_547 | |
| 0.007 | 0.12 | 0.038 | Kynurenine 3 monooxygenase inhibitor | 0.038 0.011 CID_547 | CID_547 | |
| 0.101 | 0.214 | 0.496 | Interleukin agonist | 0.496 0.009 CID_547 0.232 0.093 CID_68099 | CID_547 | |
| 0.022 | 0.137 | 0.056 | Acetylcholine M3 receptor antagonist | 0.056 0.046 CID_68099 | CID_68099 | |
| 0.006 | 0.124 | 0.037 | NMDA receptor glycine site antagonist | 0.037 0.009 CID_547 0.022 0.019 CID_68099 | CID_547 | |
| 0.018 | 0.137 | 0.236 | Prostaglandin EP2 antagonist | 0.236 0.005 CID_547 | CID_547 | |
| 0.048 | 0.168 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.138 0.018 CID_68099 | CID_68099 | |
| 0.039 | 0.16 | 0.198 | NMDA receptor antagonist | 0.198 0.014 CID_547 0.075 0.072 CID_68099 | CID_547 | |
| 0.027 | 0.149 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 CID_547 | CID_547 | |
| 0.067 | 0.195 | 0.11 | CDC-like kinase 1 inhibitor | 0.11 0.107 CID_68099 | CID_68099 | |
| 0.019 | 0.15 | 0.043 | Dihydroorotase inhibitor | 0.043 0.034 CID_547 | CID_547 | |
| 0.009 | 0.14 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 CID_547 | CID_547 | |
| 0.029 | 0.16 | 0.095 | Botulinum neurotoxin type A inhibitor | 0.083 0.015 CID_547 0.095 0.011 CID_68099 | CID_68099 | |
| 0.055 | 0.192 | 0.161 | Electrolyte absorption antagonist | 0.161 0.016 CID_547 0.123 0.034 CID_68099 | CID_547 | |
| 0.002 | 0.141 | 0.111 | Prostaglandin EP4 agonist | 0.111 0.003 CID_547 | CID_547 | |
| 0.031 | 0.17 | 0.075 | 5 Hydroxytryptamine 3 agonist | 0.075 0.031 CID_68099 | CID_68099 | |
| 0.004 | 0.144 | 0.015 | Integrin alphaVbeta6 antagonist | 0.015 0.009 CID_547 | CID_547 | |
| 0.044 | 0.183 | 0.132 | Falcipain 3 inhibitor | 0.132 0.046 CID_547 0.131 0.046 CID_68099 | CID_547 | |
| 0.017 | 0.157 | 0.067 | Sphingosine 1-phosphate receptor agonist | 0.067 0.013 CID_547 | CID_547 | |
| 0.047 | 0.187 | 0.103 | ATPase (Vacuolar H+) inhibitor | 0.103 0.036 CID_547 | CID_547 | |
| 0.048 | 0.189 | 0.099 | MDM2 inhibitor | 0.099 0.007 CID_547 | CID_547 | |
| 0.026 | 0.168 | 0.253 | Catalase inhibitor | 0.253 0.008 CID_547 0.086 0.044 CID_68099 | CID_547 | |
| 0.018 | 0.162 | 0.093 | NMDA 2 receptor antagonist | 0.093 0.035 CID_547 | CID_547 | |
| 0.022 | 0.166 | 0.057 | Matrix metalloproteinase (membrane-type) inhibitor | 0.057 0.035 CID_547 | CID_547 | |
| 0.211 | 0.358 | 0.519 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.305 0.206 CID_547 0.519 0.026 CID_68099 | CID_68099 | |
| 0.021 | 0.168 | 0.172 | Selectin antagonist | 0.172 0.014 CID_547 | CID_547 | |
| 0.024 | 0.172 | 0.072 | Matrix metalloproteinase inhibitor | 0.072 0.042 CID_547 | CID_547 | |
| 0.078 | 0.23 | 0.137 | Thiol protease inhibitor | 0.137 0.084 CID_547 0.127 0.103 CID_68099 | CID_547 | |
| 0.016 | 0.169 | 0.047 | Dihydroorotate dehydrogenase inhibitor | 0.047 0.041 CID_68099 | CID_68099 | |
| 0.064 | 0.217 | 0.142 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.142 0.082 CID_68099 | CID_68099 | |
| 0.043 | 0.197 | 0.175 | Antineoplastic alkaloid | 0.175 0.021 CID_68099 | CID_68099 | |
| 0.012 | 0.167 | 0.072 | Phosphorylase inhibitor | 0.072 0.019 CID_547 0.063 0.024 CID_68099 | CID_547 | |
| 0.023 | 0.178 | 0.068 | Glutamate (mGluR4) antagonist | 0.068 0.011 CID_547 0.057 0.015 CID_68099 | CID_547 | |
| 0.019 | 0.175 | 0.061 | AICAR transformylase inhibitor | 0.061 0.014 CID_547 | CID_547 | |
| 0.039 | 0.196 | 0.088 | Pim-3 kinase inhibitor | 0.088 0.061 CID_68099 | CID_68099 | |
| 0.008 | 0.165 | 0.04 | Lysophosphatidic acid 1 receptor antagonist | 0.04 0.004 CID_547 | CID_547 | |
| 0.059 | 0.22 | 0.106 | Glutamate (mGluR7) agonist | 0.106 0.049 CID_547 | CID_547 | |
| 0.084 | 0.247 | 0.412 | Hypolipemic | 0.412 0.023 CID_547 | CID_547 | |
| 0.009 | 0.173 | 0.064 | Nicotinic acid receptor agonist | 0.064 0.01 CID_547 0.059 0.011 CID_68099 | CID_547 | |
| 0.035 | 0.199 | 0.105 | Anesthetic local | 0.105 0.078 CID_547 | CID_547 | |
| 0.007 | 0.171 | 0.035 | Glucagon receptor antagonist | 0.035 0.016 CID_547 | CID_547 | |
| 0.011 | 0.176 | 0.061 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.061 0.006 CID_547 | CID_547 | |
| 0.024 | 0.189 | 0.091 | Carbonic anhydrase stimulant | 0.091 0.021 CID_547 | CID_547 | |
| 0.002 | 0.171 | 0.008 | Integrin alpha5beta6 antagonist | 0.008 0.004 CID_547 | CID_547 | |
| 0.028 | 0.197 | 0.069 | Phospholipase D inhibitor | 0.069 0.055 CID_547 | CID_547 | |
| 0.014 | 0.187 | 0.086 | Neutrophil collagenase inhibitor | 0.086 0.028 CID_547 | CID_547 | |
| 0.04 | 0.216 | 0.103 | Gastric antisecretory | 0.103 0.062 CID_547 | CID_547 | |
| 0.031 | 0.208 | 0.128 | DNA helicase inhibitor | 0.128 0.004 CID_547 | CID_547 | |
| 0.011 | 0.191 | 0.031 | Integrin alpha2beta1 antagonist | 0.031 0.012 CID_547 | CID_547 | |
| 0.05 | 0.231 | 0.082 | Transcription factor NF kappa B stimulant | 0.082 0.065 CID_547 | CID_547 | |
| 0.009 | 0.19 | 0.057 | Geranyltranstransferase inhibitor | 0.057 0.016 CID_547 | CID_547 | |
| 0.043 | 0.227 | 0.066 | Calcium channel P-type blocker | 0.066 0.037 CID_547 | CID_547 | |
| 0.01 | 0.198 | 0.027 | ICAM 1 antagonist | 0.027 0.009 CID_547 0.024 0.013 CID_68099 | CID_547 | |
| 0.08 | 0.269 | 0.496 | Platelet antagonist | 0.496 0.014 CID_547 | CID_547 | |
| 0.014 | 0.203 | 0.044 | Membrane dipeptidase inhibitor | 0.044 0.021 CID_547 | CID_547 | |
| 0.109 | 0.299 | 0.337 | Gastrin inhibitor | 0.337 0.014 CID_547 | CID_547 | |
| 0.018 | 0.209 | 0.045 | Glutamate (mGluR group III) agonist | 0.045 0.027 CID_547 | CID_547 | |
| 0.106 | 0.297 | 0.308 | Calpain 2 inhibitor | 0.308 0.109 CID_68099 | CID_68099 | |
| 0.006 | 0.199 | 0.018 | Integrin beta6 antagonist | 0.018 0.005 CID_547 | CID_547 | |
| 0.019 | 0.215 | 0.058 | Collagenase 3 inhibitor | 0.058 0.044 CID_547 | CID_547 | |
| 0.011 | 0.209 | 0.241 | Peroxisome proliferator-activated receptor delta antagonist | 0.241 0.004 CID_547 | CID_547 | |
| 0.004 | 0.205 | 0.074 | Free fatty acid receptor 1 agonist | 0.074 0.004 CID_547 | CID_547 | |
| 0.013 | 0.215 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.025 CID_547 | CID_547 | |
| 0.059 | 0.262 | 0.131 | Histone deacetylase SIRT1 inhibitor | 0.131 0.079 CID_547 | CID_547 | |
| 0.007 | 0.213 | 0.065 | Prostaglandin EP4 antagonist | 0.065 0.006 CID_547 | CID_547 | |
| 0.004 | 0.211 | 0.014 | Prostacyclin agonist | 0.014 0.013 CID_547 | CID_547 | |
| 0.014 | 0.227 | 0.046 | Integrin alpha2 antagonist | 0.046 0.014 CID_547 | CID_547 | |
| 0.079 | 0.295 | 0.132 | Pregnane X receptor agonist | 0.132 0.095 CID_547 | CID_547 | |
| 0.011 | 0.228 | 0.058 | Glycine transporter 2 inhibitor | 0.058 0.026 CID_547 | CID_547 | |
| 0.014 | 0.234 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.028 CID_547 | CID_547 | |
| 0.05 | 0.273 | 0.145 | Cathepsin H inhibitor | 0.145 0.05 CID_547 0.111 0.088 CID_68099 | CID_547 | |
| 0.014 | 0.238 | 0.09 | AMPA 4 receptor antagonist | 0.09 0.005 CID_547 0.044 0.02 CID_68099 | CID_547 | |
| 0.007 | 0.234 | 0.043 | Protocollagen prolyl hydroxylase inhibitor | 0.043 0.007 CID_547 | CID_547 | |
| 0.021 | 0.251 | 0.054 | Angiotensin-converting enzyme inhibitor | 0.054 0.04 CID_547 | CID_547 | |
| 0.022 | 0.256 | 0.057 | Epithelial sodium channel blocker | 0.057 0.034 CID_547 | CID_547 | |
| 0.083 | 0.318 | 0.202 | Lipocortins synthesis antagonist | 0.202 0.055 CID_547 | CID_547 | |
| 0.005 | 0.243 | 0.031 | HMG CoA reductase inhibitor | 0.031 0.03 CID_547 | CID_547 | |
| 0.032 | 0.273 | 0.084 | Sphingosine 1-phosphate receptor antagonist | 0.084 0.039 CID_547 | CID_547 | |
| 0.014 | 0.257 | 0.056 | Tryptophan 5 hydroxylase inhibitor | 0.056 0.004 CID_547 | CID_547 | |
| 0.1 | 0.35 | 0.179 | Neuropeptide Y2 antagonist | 0.179 0.163 CID_547 | CID_547 | |
| 0.002 | 0.259 | 0.039 | Kainate receptor 1 antagonist | 0.039 0.007 CID_547 0.031 0.01 CID_68099 | CID_547 | |
| 0.007 | 0.268 | 0.027 | Calcium-sensing receptor agonist | 0.027 0.017 CID_547 | CID_547 | |
| 0.005 | 0.273 | 0.055 | AMPA 3 receptor antagonist | 0.055 0.007 CID_547 | CID_547 | |
| 0.076 | 0.345 | 0.277 | Thioredoxin glutathione reductase inhibitor | 0.277 0.117 CID_68099 | CID_68099 | |
| 0.005 | 0.275 | 0.052 | Antimetabolite | 0.052 0.03 CID_547 | CID_547 | |
| 0.003 | 0.276 | 0.049 | AMPA 1 receptor antagonist | 0.049 0.011 CID_547 0.043 0.013 CID_68099 | CID_547 | |
| 0.089 | 0.365 | 0.236 | Catenin beta inhibitor | 0.236 0.014 CID_547 | CID_547 | |
| 0.009 | 0.287 | 0.055 | Thymidylate synthase inhibitor | 0.055 0.022 CID_547 | CID_547 | |
| 0.017 | 0.303 | 0.111 | Sphingosine 1-phosphate receptor 5 agonist | 0.111 0.007 CID_547 | CID_547 | |
| 0.007 | 0.294 | 0.025 | Retinoid X gamma receptor antagonist | 0.025 0.024 CID_547 | CID_547 | |
| 0.019 | 0.312 | 0.061 | Sphingosine 1-phosphate receptor 1 antagonist | 0.061 0.028 CID_547 | CID_547 | |
| 0.004 | 0.3 | 0.086 | Kainate receptor antagonist | 0.086 0.009 CID_547 0.061 0.016 CID_68099 | CID_547 | |
| 0.005 | 0.311 | 0.058 | AMPA receptor antagonist | 0.052 0.029 CID_547 0.058 0.026 CID_68099 | CID_68099 | |
| 0.004 | 0.317 | 0.047 | Retinoid X beta receptor agonist | 0.047 0.005 CID_547 | CID_547 | |
| 0.014 | 0.328 | 0.231 | Purinergic P2X2 antagonist | 0.231 0.003 CID_68099 | CID_68099 | |
| 0.021 | 0.339 | 0.181 | M17 leucyl aminopeptidase inhibitor | 0.181 0.04 CID_547 | CID_547 | |
| 0.034 | 0.359 | 0.184 | LIM domain kinase 1 inhibitor | 0.184 0.071 CID_68099 | CID_68099 | |
| 0.008 | 0.336 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.028 CID_547 | CID_547 | |
| 0.013 | 0.344 | 0.029 | Elastase 3B inhibitor | 0.029 0.025 CID_547 | CID_547 | |
| 0.013 | 0.344 | 0.029 | Elastase 3A inhibitor | 0.029 0.025 CID_547 | CID_547 | |
| 0.013 | 0.344 | 0.029 | Elastase 2B inhibitor | 0.029 0.025 CID_547 | CID_547 | |
| 0.004 | 0.338 | 0.034 | Sphingosine 1-phosphate receptor 3 agonist | 0.034 0.025 CID_547 | CID_547 | |
| 0.006 | 0.343 | 0.042 | Angiotensin AT1 receptor antagonist | 0.042 0.029 CID_547 | CID_547 | |
| 0.005 | 0.344 | 0.046 | Carnitine palmitoyltransferase 1 inhibitor | 0.046 0.01 CID_547 | CID_547 | |
| 0.004 | 0.353 | 0.047 | Carnitine palmitoyltransferase inhibitor | 0.047 0.01 CID_547 | CID_547 | |
| 0.004 | 0.359 | 0.073 | Kainate receptor 2 antagonist | 0.073 0.008 CID_547 0.044 0.019 CID_68099 | CID_547 | |
| 0.01 | 0.421 | 0.036 | Erythropoietin receptor agonist | 0.036 0.032 CID_547 | CID_547 | |
| 0.005 | 0.418 | 0.045 | Prostaglandin E2 antagonist | 0.045 0.04 CID_547 | CID_547 | |
| 0.03 | 0.448 | 0.118 | Interleukin 1b antagonist | 0.118 0.064 CID_547 | CID_547 | |
| 0.004 | 0.423 | 0.045 | Retinoid X gamma receptor agonist | 0.045 0.006 CID_547 | CID_547 | |
| 0.009 | 0.443 | 0.073 | Diacylglycerol O-acyltransferase inhibitor | 0.073 0.018 CID_547 | CID_547 | |
| 0.021 | 0.455 | 0.096 | GABA receptor agonist | 0.096 0.081 CID_68099 | CID_68099 | |
| 0.09 | 0.531 | 0.483 | Interleukin 2 agonist | 0.483 0.01 CID_547 0.247 0.122 CID_68099 | CID_547 | |
| 0.009 | 0.464 | 0.095 | Plasminogen activator inhibitor | 0.095 0.018 CID_68099 | CID_68099 | |
| 0.008 | 0.464 | 0.022 | Granulocyte colony stimulating factor receptor agonist | 0.022 0.005 CID_68099 | CID_68099 | |
| 0.021 | 0.481 | 0.075 | Chymotrypsin inhibitor | 0.075 0.061 CID_547 | CID_547 | |
| 0.004 | 0.465 | 0.049 | Prostaglandin D2 agonist | 0.049 0.008 CID_547 | CID_547 | |
| 0.014 | 0.476 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.029 CID_547 | CID_547 | |
| 0.003 | 0.5 | 0.046 | Squalene synthetase inhibitor | 0.046 0.016 CID_547 | CID_547 | |
| 0.047 | 0.566 | 0.364 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.364 0.022 CID_68099 | CID_68099 | |
| 0.009 | 0.531 | 0.044 | VCAM-1 antagonist | 0.044 0.016 CID_547 | CID_547 | |
| 0.009 | 0.532 | 0.044 | VCAM antagonist | 0.044 0.016 CID_547 | CID_547 | |
| 0.049 | 0.574 | 0.53 | Toll-Like receptor 7 agonist | 0.53 0.026 CID_547 | CID_547 | |
| 0.005 | 0.542 | 0.094 | Fibroblast growth factor 4 antagonist | 0.094 0.011 CID_68099 | CID_68099 | |
| 0.044 | 0.591 | 0.524 | Toll-Like receptor agonist | 0.524 0.027 CID_547 | CID_547 | |
| 0.044 | 0.604 | 0.261 | Growth hormone agonist | 0.261 0.041 CID_547 | CID_547 | |
| 0.003 | 0.593 | 0.031 | Integrin beta7 antagonist | 0.031 0.009 CID_547 | CID_547 | |
| 0.003 | 0.621 | 0.045 | Prostaglandin EP3 antagonist | 0.045 0.012 CID_547 | CID_547 | |
| 0.004 | 0.648 | 0.601 | Prostaglandin antagonist | 0.601 0.004 CID_547 | CID_547 | |
| 0.011 | 0.664 | 0.166 | Anticoagulant | 0.166 0.068 CID_547 | CID_547 | |
| 0.015 | 0.674 | 0.238 | Platelet aggregation inhibitor | 0.238 0.057 CID_547 | CID_547 | |
| 0.009 | 0.684 | 0.099 | Prostaglandin F2 alpha antagonist | 0.099 0.012 CID_547 | CID_547 | |
| 0.018 | 0.704 | 0.063 | Caspase 9 inhibitor | 0.063 0.041 CID_547 | CID_547 | |
| 0.017 | 0.725 | 0.143 | Nav1.4 sodium channel blocker | 0.143 0.037 CID_547 | CID_547 | |
| 0.002 | 0.727 | 0.068 | VLA-4 antagonist | 0.068 0.009 CID_547 | CID_547 | |
| 0.015 | 0.77 | 0.294 | Antiobesity | 0.294 0.121 CID_547 | CID_547 | |
| 0.004 | 0.778 | 0.054 | Glucagon-like peptide 1 agonist | 0.054 0.053 CID_547 | CID_547 | |
| 0.01 | 0.785 | 0.259 | Cell adhesion inhibitor | 0.259 0.014 CID_547 | CID_547 | |
| 0.003 | 0.783 | 0.02 | Integrin alphaVbeta1 antagonist | 0.02 0.012 CID_547 | CID_547 | |
| 0.003 | 0.832 | 0.03 | Vitronectin receptor antagonist | 0.03 0.01 CID_547 | CID_547 | |
| 0.002 | 0.836 | 0.505 | Prostaglandin D2 antagonist | 0.505 0.003 CID_547 | CID_547 | |
| 0.003 | 0.857 | 0.049 | AMPA 2 receptor antagonist | 0.049 0.011 CID_547 | CID_547 | |
| 0.002 | 0.858 | 0.07 | GP IIb/IIIa receptor antagonist | 0.07 0.024 CID_547 | CID_547 | |
| 0.007 | 0.869 | 0.049 | Autotaxin inhibitor | 0.049 0.043 CID_547 | CID_547 | |
| 0.003 | 0.878 | 0.022 | Integrin alphaVbeta3 antagonist | 0.022 0.015 CID_547 | CID_547 | |
| 0.022 | 0.898 | 0.106 | Folate antagonist | 0.106 0.055 CID_547 | CID_547 | |
| 0.003 | 0.884 | 0.024 | Integrin beta5 antagonist | 0.024 0.011 CID_547 | CID_547 | |
| 0.007 | 0.892 | 0.113 | Carnitine palmitoyltransferase 1B inhibitor | 0.113 0.004 CID_547 | CID_547 | |
| 0.004 | 0.895 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.012 CID_547 | CID_547 | |
| 0.004 | 0.909 | 0.043 | Integrin alpha5beta1 antagonist | 0.043 0.025 CID_547 | CID_547 | |
| 0.002 | 0.912 | 0.033 | Integrin alpha4beta7 antagonist | 0.033 0.008 CID_547 | CID_547 | |
| 0.002 | 0.922 | 0.035 | Kainate receptor 4 antagonist | 0.035 0.011 CID_68099 | CID_68099 | |
| 0.003 | 0.928 | 0.124 | Integrin antagonist | 0.124 0.013 CID_547 | CID_547 | |
| 0.002 | 0.929 | 0.065 | Integrin alpha4 antagonist | 0.065 0.009 CID_547 | CID_547 | |
| 0.004 | 0.934 | 0.141 | Cell adhesion molecule inhibitor | 0.141 0.017 CID_547 | CID_547 | |
| 0.002 | 0.933 | 0.033 | Carnitine palmitoyltransferase 1A inhibitor | 0.033 0.014 CID_547 | CID_547 | |
| 0.004 | 0.935 | 0.058 | p53 inhibitor | 0.058 0.01 CID_547 | CID_547 | |
| 0.002 | 0.938 | 0.019 | Kainate receptor 5 antagonist | 0.019 0.016 CID_68099 | CID_68099 | |
| 0.007 | 0.963 | 0.036 | Integrin alpha1beta1 antagonist | 0.036 0.033 CID_547 | CID_547 | |
| 0.002 | 0.962 | 0.081 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.081 0.005 CID_547 | CID_547 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |